Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Armata Pharmaceuticals, Inc. | Financial_Report.xls |
| EX-3.5 - EXHIBIT 3.5 - Armata Pharmaceuticals, Inc. | v407144_ex3-5.htm |
| EX-23.1 - EXHIBIT 23.1 - Armata Pharmaceuticals, Inc. | v407144_ex23-1.htm |
| EX-14.1 - EXHIBIT 14.1 - Armata Pharmaceuticals, Inc. | v407144_ex14-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Armata Pharmaceuticals, Inc. | v407144_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Armata Pharmaceuticals, Inc. | v407144_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - Armata Pharmaceuticals, Inc. | v407144_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Armata Pharmaceuticals, Inc. | v407144_ex32-1.htm |
| 10-K - FORM 10-K - Armata Pharmaceuticals, Inc. | v407144_10k.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement (No. 333-193458) on Form S-1 of AmpliPhi Biosciences Corporation of our report dated April 15, 2015 relating to our audit of the consolidated financial statements for the year ended December 31, 2013, which appear in the Annual Report to Shareholders, which is incorporated in this Annual Report on Form 10-K of AmpliPhi Biosciences Corporation for the year ended December 31, 2014.
/s/ PBMares, LLP
Richmond, Virginia
April 15, 2015